Highlights

NMRC $25M to Develop Next - Gen Gastric Cancer Solution

NMRC $25M to Develop Next - Gen Gastric Cancer Solution

Dr Jonathan Lee, together with a team of clinicians from National University Hospital (NUH), Duke-NUS, Singapore General Hospital (SGH), National University Cancer Institute, Singapore (NCIS), and the National Cancer Centre Singapore (NCCS), has secured $25 million in funding from the National Medical Research Council (NMRC) for a five-year research programme. The team aims to develop AI-driven tools for the prevention, early detection, and treatment of gastric cancer.

"Survey on the perceptions of Asian endoscopists to artificial intelligence" published in Communications Medicine

Led by our Principal Investigator Dr. Jonathan Lee as the correspondent author, the publication Survey on the perceptions of Asian endoscopists to artificial intelligence presents findings from an international survey spanning multiple Asian countries. It delves into Asian endoscopists' views on AI in their field, uncovering insights that can shape the integration of AI tools in endoscopic practices across the region. These insights contribute to advancing AI - driven solutions in gastrointestinal care.

Research Focus

Microbiome Core

Microbiome Core

Our research aims to advance understanding of the gut microbiome by employing cutting-edge techniques to analyze and characterize microbial communities and their impact on health.

AI-Powered Endoscopy

AI-Powered Endoscopy

We leverage artificial intelligence to enhance endoscopic imaging and diagnostics, enabling more accurate detection and characterization of gastrointestinal diseases.

Translational Research Unit

Translational Research Unit

Our work explores the therapeutic potential and mechanisms of fecal microbiota transplantation to restore gut microbial balance and treat gastrointestinal disorders.

Gut-Brain Core

Gut-Brain Core

The Gut–Brain Core, led by Adjunct Associate Professor Kewin Siah, is advancing research into disorders of gut–brain interaction (DGBI) with a focus on Asia-relevant evidence and therapies..

Funding Sources